These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4297 related articles for article (PubMed ID: 10387986)

  • 1. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased resistance of PIG-A- bone marrow progenitors to tumor necrosis factor a and interferon gamma: possible implications for the in vivo dominance of paroxysmal nocturnal hemoglobinuria clones.
    Barcellini W; Fermo E; Guia Imperiali F; Zaninoni A; Bianchi P; Boschetti C; Zanella A
    Haematologica; 2004 Jun; 89(6):651-6. PubMed ID: 15194531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired aplastic anemia.
    Keohane EM
    Clin Lab Sci; 2004; 17(3):165-71. PubMed ID: 15314891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-3 in hematology and oncology: current state of knowledge and future directions.
    Mangi MH; Newland AC
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):87-95. PubMed ID: 10515681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aplastic anemia.
    Storb R
    J Intraven Nurs; 1997; 20(6):317-22. PubMed ID: 9423394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
    Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
    Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia.
    Wodnar-Filipowicz A; Lyman SD; Gratwohl A; Tichelli A; Speck B; Nissen C
    Blood; 1996 Dec; 88(12):4493-9. PubMed ID: 8977241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum stem cell factor levels in patients with aplastic anemia.
    Nimer SD; Leung DH; Wolin MJ; Golde DW
    Int J Hematol; 1994 Oct; 60(3):185-9. PubMed ID: 7532030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
    Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure.
    Maciejewski JP; Hibbs JR; Anderson S; Katevas P; Young NS
    Exp Hematol; 1994 Oct; 22(11):1102-10. PubMed ID: 7925777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal nocturnal hemoglobinuria: the price for a chance.
    Bessler M
    Schweiz Med Wochenschr; 1996 Nov; 126(45):1912-21. PubMed ID: 8946596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special Education.
    Kozutsumi H
    Oncologist; 1996; 1(1 & 2):116-118. PubMed ID: 10387976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
    Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
    Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defunct hematopoietic progenitor growth and heterogeneous immunological phenotypes in acquired aplastic anemia of childhood: identification of subsets with decreased hematopoietic progenitors and increased IL15 or IL10 production.
    Dirksen U; Asadi-Moghaddam K; Führer M; Burdach S
    Klin Padiatr; 1998; 210(4):167-72. PubMed ID: 9743948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF.
    Bacigalupo A; Piaggio G; Podestà M; Tong J; Pitto A; Figari O; Benvenuto F; Vassallo F; Tedone E; Grassia L; Van Lint MT; Gualandi F; Hoffman R
    Haematologica; 1997; 82(2):133-7. PubMed ID: 9175313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 215.